Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sotirios P. Sachanas
Observed names:
S Sachanas,
S. Sachanas,
SOTIRIOS SACHANAS,
Sotirios Sachanas,
Σωτήριος Σαχανάς
Institution:
Athens Medical Center
Observed institutions:
Roswell Park Comprehensive Cancer Center,
National and Kapodistrian University of Athens,
Laiko General Hospital of Athens,
Athens Medical Center,
University at Buffalo, State University of New York
ORCID:
0000-0003-4818-8033
Observed ORCID:
0000-0003-4818-8033
OpenAlex ID:
A5039544898
Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma
2007
·
Marie‐Christine Kyrtsonis
, Theodoros P. Vassilakopoulos
, et al.
·
British Journal of Haematology
·
130
Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone with or Without Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma: The Emerging Standard of Care
2012
·
Theodoros P. Vassilakopoulos
, Gerassimos A. Pangalis
, et al.
·
The Oncologist
·
127
Treatment of Splenic Marginal Zone Lymphoma With Rituximab Monotherapy: Progress Report and Comparison With Splenectomy
2013
·
Christina Kalpadakis
, Gerassimos A. Pangalis
, et al.
·
The Oncologist
·
92
Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?
2013
·
Aliki Xochelli
, Christina Kalpadakis
, et al.
·
Blood
·
91
Alveolar bone histological necrosis observed prior to extractions in patients, who received bone‐targeting agents
2020
·
Ourania Nicolatou‐Galitis
, Erofili Papadopoulou
, et al.
·
Oral Diseases
·
67
Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance
2018
·
Christina Kalpadakis
, Gerassimos A. Pangalis
, et al.
·
Blood
·
62
PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy
2015
·
T P Vassilakopoulos
, G A Pangalis
, et al.
·
Leukemia
·
52
Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned?
2013
·
Christina Kalpadakis
, Gerassimos A. Pangalis
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
44
Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas
2021
·
Maria Dimou
, Sotirios G. Papageorgiou
, et al.
·
Hematological Oncology
·
39
Combination of rituximab with chlorambucil as first line treatment in patients with mantle cell lymphoma: a highly effective regimen
2010
·
Sotirios Sachanas
, Gerassimos A. Pangalis
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
38
Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib
2008
·
K. Anargyrou
, E. Terpos
, et al.
·
Haematologica
·
32
PDF
Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP
2021
·
Theodoros P. Vassilakopoulos
, Michail Michail
, et al.
·
The Oncologist
·
29
PDF
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies
2021
·
Theodoros P. Vassilakopoulos
, Sotirios G. Papageorgiou
, et al.
·
Annals of Hematology
·
27
Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens
2016
·
Theodoros P. Vassilakopoulos
, Maria N. Dimopoulou
, et al.
·
The Oncologist
·
26
PDF
Exuberant cortical thymocyte proliferation mimicking T-lymphoblastic lymphoma within recurrent large inguinal lymph node masses of localized Castleman disease
2015
·
Rina Kansal
, Bharat N. Nathwani
, et al.
·
Human Pathology
·
25
New Insights into Monoclonal B-Cell Lymphocytosis
2014
·
Christina Kalpadakis
, Gerassimos A. Pangalis
, et al.
·
BioMed Research International
·
23
PDF
Immunohistochemical Analysis of IL-6, IL-8/CXCR2 Axis, Tyrp -STAT-3, and SOCS-3 in Lymph Nodes from Patients with Chronic Lymphocytic Leukemia: Correlation between Microvascular Characteristics and Prognostic Significance
2014
·
Georgia Levidou
, Sotirios Sachanas
, et al.
·
BioMed Research International
·
23
PDF
Outcome and toxicity in relapsed hairy cell leukemia patients treated with rituximab
2008
·
Maria K. Angelopoulou
, Gerassimos A. Pangalis
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
22
Primary effusion lymphoma in two HIV-negative patients successfully treated with pleurodesis as first-line therapy.
2010
·
X Yiakoumis
, G A Pangalis
, et al.
·
PubMed
·
20
The Significance of PET/CT in the Initial Staging of Hodgkin Lymphoma: Experience Outside Clinical Trials
2017
·
MARIA K. ANGELOPOULOU
, EFTYCHIA MOSA
, et al.
·
Anticancer Research
·
19
Should rituximab replace splenectomy in the management of splenic marginal zone lymphoma?
2017
·
Christina Kalpadakis
, Gerassimos A. Pangalis
, et al.
·
Best Practice & Research Clinical Haematology
·
18
Validation of the simplified prognostic score for splenic marginal zone lymphoma of the Splenic Marginal Zone Lymphoma Working Group
2014
·
Christina Kalpadakis
, Gerassimos A. Pangalis
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
18
Early-Stage Gastric MALT Lymphoma: Is It a Truly Localized Disease?
2009
·
Marina P. Siakantaris
, Gerassimos A. Pangalis
, et al.
·
The Oncologist
·
18
PDF
Clinical Aspects of Malt Lymphomas
2014
·
Christina Kalpadakis
, Gerassimos A. Pangalis
, et al.
·
Current Hematologic Malignancy Reports
·
17
Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia
2014
·
Marie-Christine Kyrtsonis
, Katerina Sarris
, et al.
·
BioMed Research International
·
16
PDF
Show more works
View as search
Works count:
89
Citation count:
1,293
H-index:
19
I10-index:
36
Year
Topic
Type
